VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CBUSCibus, Inc.
$1.36$887M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

CBUS logoCibus, Inc.(CBUS)Earnings, Financials & Key Ratios

CBUS•NASDAQ
Price updated Jun 17, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryRoyalty and IP Monetization Vehicles
AboutCibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.Show more
  • Revenue$4M-14.6%
  • EBITDA-$62M+75.5%
  • Net Income-$127M+49.4%
  • EPS (Diluted)-2.78+74.3%
  • Gross Margin-62.76%-162.8%
  • EBITDA Margin-1691.15%+71.3%
  • Operating Margin-1853.92%+69.4%
  • Net Margin-3492.31%+40.8%
  • ROE-212.41%-84.3%

CBUS Key Insights

Cibus, Inc. (CBUS) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

  • ✗High debt to equity ratio of 12.3x
  • ✗Profits declining 23.2% over 5 years
  • ✗Weak Piotroski F-Score: 2/9
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 17 (bottom 17%)
  • ✗Low quality earnings: Net income not backed by cash flow

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when CBUS posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CBUS Price & Volume

Cibus, Inc. (CBUS) stock price & volume — 10-year historical chart

Loading chart...

CBUS Growth Metrics

Cibus, Inc. (CBUS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years11.08%
5 Years-31.34%
3 Years185.12%
TTM-9.79%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM63.1%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM84.82%

Return on Capital

10 Years-61.21%
5 Years-70.01%
3 Years-66.55%
Last Year-21.82%

CBUS Recent Earnings

Cibus, Inc. (CBUS) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 14, 2026
Metric
Actual
Est
EPS
$0.33+5.7%
$0.35
Rev
$2M+4.7%
$2M
Q2 2026
Mar 17, 2026
Metric
Actual
Est
EPS
$0.42+2.3%
$0.43
Rev
$1M-35.7%
$2M
Q4 2025
Nov 13, 2025
Metric
Actual
Est
EPS
$0.44-7.3%
$0.41
Rev
$615,000-62.6%
$2M
Q3 2025
Aug 14, 2025
Metric
Actual
Est
EPS
$0.61+11.6%
$0.69
Rev
$933,000-38.3%
$2M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 14, 2026
$0.33vs $0.35+5.7%
$2Mvs $2M+4.7%
Q2 2026Mar 17, 2026
$0.42vs $0.43+2.3%
$1Mvs $2M-35.7%
Q4 2025Nov 13, 2025
$0.44vs $0.41-7.3%
$615,000vs $2M-62.6%
Q3 2025Aug 14, 2025
$0.61vs $0.69+11.6%
$933,000vs $2M-38.3%
Based on last 12 quarters of dataView full earnings history →

CBUS Peer Comparison

Cibus, Inc. (CBUS) competitors in Royalty and IP Monetization Vehicles — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
PGEN logoPGENPrecigen, Inc.Direct Competitor1.42B4.73-3.35146.73%-6.47%-17.69%0.24
RKDA logoRKDAArcadia Biosciences, Inc.Direct Competitor1.3M0.84-0.49-3.71%-195.94%-219.35%
SEED logoSEEDOrigin Agritech LimitedDirect Competitor7.35M0.98-0.94-20.52%-42.61%
APLD logoAPLDApplied Digital CorporationDirect Competitor13.04B45.57-39.2857.74%-43.49%-6.23%1.11
OFIX logoOFIXOrthofix Medical Inc.Direct Competitor373.09M9.23-4.052.85%-7.27%-13.44%0.51
CTVA logoCTVACorteva, Inc.Product Competitor51.94B77.3748.362.92%6.5%4.62%0.11
FMC logoFMCFMC CorporationProduct Competitor1.5B11.98-0.67-18.34%-72.93%-82.27%2.00
BIOX logoBIOXBioceres Crop Solutions Corp.Product Competitor24.94M0.39-0.48-28.3%-82.77%-92.01%0.94

Compare CBUS vs Peers

Cibus, Inc. (CBUS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs PGEN

Most directly comparable listed peer for CBUS.

Scale Benchmark

vs DE

Larger-name benchmark to compare CBUS against a more recognizable public peer.

Peer Set

Compare Top 5

vs PGEN, RKDA, SEED, APLD

CBUS Income Statement

Cibus, Inc. (CBUS) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
508K236K7.3M23.85M25.99M157K1.82M4.26M3.64M4.29M
Revenue Growth %
27.32%-53.54%2991.53%226.91%8.96%-99.4%1057.32%134.56%-14.62%-9.79%
Cost of Goods Sold
551K1.08M9.28M35.13M28.56M1.53M395K05.92M1.2M
COGS % of Revenue
108.46%458.05%127.19%147.28%109.89%977.07%21.74%-162.76%-
Gross Profit
-43K▲ 0%
-845K▼ 1865.1%
-1.98M▼ 134.8%
-11.28M▼ 468.3%
-2.57M▲ 77.2%
-1.38M▲ 46.4%
1.42M▲ 203.3%
4.26M▲ 199.7%
-2.28M▼ 153.6%
3.09M▲ 0%
Gross Margin %
-8.46%-358.05%-27.19%-47.28%-9.89%-877.07%78.26%100%-62.76%72.07%
Gross Profit Growth %
-121.61%-1865.12%-134.79%-468.35%77.21%46.42%203.27%199.72%-153.59%-
Operating Expenses
26.3M28.35M37.69M32.56M26.76M20.99M320.31M262.66M65.18M62.05M
OpEx % of Revenue
5176.57%12013.14%516.57%136.5%102.98%13371.34%17628.23%6162.79%1791.15%-
Selling, General & Admin
14.74M18.5M24.14M20.79M15.38M9.44M28.91M30.8M26.91M22.13M
SG&A % of Revenue
2901.77%7841.1%330.84%87.16%59.19%6012.74%1591.3%722.6%739.35%-
Research & Development
11.56M9.85M12.21M11.08M11.34M11.55M42.37M50.43M44.2M41.12M
R&D % of Revenue
2274.8%4172.03%167.39%46.46%43.62%7358.6%2331.7%1183.22%1214.56%-
Other Operating Expenses
001.34M685K19K0249.02M181.43M-5.92M-1000K
Operating Income
-25.79M▲ 0%
-28.11M▼ 9.0%
-39.67M▼ 41.1%
-43.83M▼ 10.5%
-29.33M▲ 33.1%
-22.37M▲ 23.7%
-318.88M▼ 1325.5%
-258.4M▲ 19.0%
-67.46M▲ 73.9%
-58.96M▲ 0%
Operating Margin %
-5076.57%-11913.14%-543.76%-183.77%-112.87%-14248.41%-17549.97%-6062.79%-1853.92%-1375.71%
Operating Income Growth %
-112.97%-9.02%-41.11%-10.48%33.08%23.74%-1325.49%18.97%73.89%-
EBITDA
-25.24M-27.03M-38.07M-41.96M-26.99M-20.84M-314.19M-251.54M-61.54M-53.48M
EBITDA Margin %
-4968.11%-11455.08%-521.74%-175.94%-103.88%-13271.34%-17291.69%-5901.85%-1691.15%-1247.71%
EBITDA Growth %
-114.54%-7.12%-40.81%-10.24%35.67%22.81%-1407.92%19.94%75.53%78.94%
D&A (Non-Cash Add-back)
551K1.08M1.61M1.87M2.34M1.53M4.69M6.86M5.92M5.49M
EBIT
-25.72M-26.64M-38.12M-43.4M-27.77M-16.74M-318.75M-248.49M-96.69M-67.8M
Net Interest Income
-1K264K110K-878K-1.41M-27K-18.36M-33.56M-35.04M-17.66M
Interest Income
01.52M1.6M557K17K60K527K631K438K347K
Interest Expense
1K1.26M1.49M1.44M1.43M87K18.89M34.19M35.48M17.98M
Other Income/Expense
-191K218K61K-1M133K5.48M-18.76M-24.29M-64.71M-45.03M
Pretax Income
-25.98M▲ 0%
-27.9M▼ 7.4%
-39.61M▼ 42.0%
-44.84M▼ 13.2%
-29.2M▲ 34.9%
-16.89M▲ 42.2%
-337.64M▼ 1899.0%
-282.68M▲ 16.3%
-132.17M▲ 53.2%
-104M▲ 0%
Pretax Margin %
-5114.17%-11820.76%-542.93%-187.98%-112.36%-10758.6%-18582.44%-6632.66%-3632.1%-2426.43%
Income Tax
1K00000-4K29K29K34K
Effective Tax Rate %
-0%0%0%0%0%0%0%-0.01%-0.02%-0.03%
Net Income
-25.98M▲ 0%
-27.9M▼ 7.4%
-39.61M▼ 42.0%
-44.84M▼ 13.2%
-29.2M▲ 34.9%
-16.89M▲ 42.2%
-267.63M▼ 1484.4%
-251.39M▲ 6.1%
-127.08M▲ 49.4%
-101.42M▲ 0%
Net Margin %
-5114.17%-11820.76%-542.93%-187.98%-112.36%-10758.6%-14729.06%-5898.36%-3492.31%-2366.33%
Net Income Growth %
-114.96%-7.38%-41.99%-13.19%34.88%42.15%-1484.44%6.07%49.45%63.1%
Net Income (Continuing)
-25.98M-27.9M-39.61M-44.84M-29.2M-16.89M-337.64M-282.71M-132.2M-104.03M
Discontinued Operations
0000000000
Minority Interest
00000044.82M5.67M00
EPS (Diluted)
-56.10▲ 0%
-45.46▲ 19.0%
-60.37▼ 32.8%
-66.16▼ 9.6%
-0.05▲ 99.9%
-0.03▲ 42.2%
-25.95▼ 88769.9%
-10.83▲ 58.3%
-2.78▲ 74.3%
-0.16▲ 0%
EPS Growth %
-146.92%18.97%-32.8%-9.59%99.92%42.18%-88769.86%58.27%74.33%84.82%
EPS (Basic)
-56.10-45.46-60.37-66.16-0.05-0.03-25.95-10.83-2.78-
Diluted Shares Outstanding
463.07M613.67M656.11M677.65M578.47M578.47M10.31M23.22M457.57M652.02M
Basic Shares Outstanding
463.07M613.67M656.11M677.65M578.47M578.47M10.31M23.22M457.57M652.02M
Dividend Payout Ratio
----------

CBUS Balance Sheet

Cibus, Inc. (CBUS) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
57.46M95.52M63.52M39.59M15.18M4.13M35.22M16.95M12.07M33.07M
Cash & Short-Term Investments
56.66M93.79M58.61M29M13.82M3.43M32.7M14.43M9.92M30.32M
Cash Only
56.66M93.79M58.61M17.3M13.82M3.43M32.7M14.43M9.92M30.32M
Short-Term Investments
00011.7M000000
Accounts Receivable
167K46K1.12M4.89M00530K1.04M703K1.8M
Days Sales Outstanding
119.9971.1456.1374.79--106.4789.1570.5186.5
Inventory
01.31M2.59M1.38M000000
Days Inventory Outstanding
-444.01102.0314.37------
Other Current Assets
138K67K388K393K499K705K1.99M1.47M1.44M941K
Total Non-Current Assets
14.71M23.27M24.58M23.74M22.01M18.29M509.19M333.12M292.98M291.13M
Property, Plant & Equipment
14.35M21.85M23.21M22.86M21.73M18.13M37.46M44.69M27.86M26.57M
Fixed Asset Turnover
0.04x0.01x0.31x1.04x1.20x0.01x0.05x0.10x0.13x0.13x
Goodwill
000000434.9M253.47M232.52M232.52M
Intangible Assets
00000158K35.41M33.58M31.68M31.22M
Long-Term Investments
01.11M00000000
Other Non-Current Assets
357K306K1.36M877K282K01.42M1.39M926K824K
Total Assets
72.17M▲ 0%
118.79M▲ 64.6%
88.1M▼ 25.8%
63.33M▼ 28.1%
37.19M▼ 41.3%
22.42M▼ 39.7%
544.41M▲ 2328.1%
350.07M▼ 35.7%
305.05M▼ 12.9%
324.2M▲ 0%
Asset Turnover
0.01x0.00x0.08x0.38x0.70x0.01x0.00x0.01x0.01x0.01x
Asset Growth %
334.14%64.61%-25.84%-28.12%-41.27%-39.72%2328.13%-35.7%-12.86%-63.77%
Total Current Liabilities
4.25M7M7.2M6.95M4.85M1.66M21.32M19.88M16.86M13.94M
Accounts Payable
1.02M818K1.08M929K1.26M340K6.13M5.96M8.07M5.41M
Days Payables Outstanding
677.67276.242.369.6516.180.95.66K-497.311.94K
Short-Term Debt
1.35M00000833K436K3.17M2.96M
Deferred Revenue (Current)
43K248K000107K1.21M932K536K2.83M
Other Current Liabilities
78K1.77M2.24M2M2.71M403K5.29M5.87M5.09M2.12M
Current Ratio
13.51x13.64x8.83x5.70x3.13x2.49x1.65x0.85x0.72x2.37x
Quick Ratio
13.51x13.45x8.47x5.50x3.13x2.49x1.65x0.85x0.72x2.37x
Cash Conversion Cycle
-238.96115.879.5------1.85K
Total Non-Current Liabilities
10.44M18.39M18.39M19.51M18.21M13.53M184.79M232.36M266.36M274.78M
Long-Term Debt
0001.52M00536K226K235.02M244.12M
Capital Lease Obligations
10.15M18.23M18.24M17.88M17.51M13.45M17.14M31.22M29.78M120.48M
Deferred Tax Liabilities
-10.15M000000000
Other Non-Current Liabilities
0163K150K113K702K79K167.12M200.91M1.56M1.58M
Total Liabilities
14.69M25.39M25.59M26.45M23.06M15.19M206.12M252.24M283.22M288.72M
Total Debt
10.15M18.48M18.6M19.76M17.88M13.91M24.62M36.29M267.96M276.15M
Net Debt
-46.52M-75.31M-40.01M2.46M4.05M10.48M-8.08M21.85M258.04M245.83M
Debt / Equity
0.18x0.20x0.30x0.54x1.26x1.92x0.07x0.37x12.28x7.78x
Debt / EBITDA
----------5.16x
Net Debt / EBITDA
----------4.60x
Interest Coverage
-25719.00x-21.19x-25.59x-30.24x-19.40x-192.46x-16.87x-7.27x-2.73x-3.77x
Total Equity
57.48M▲ 0%
93.4M▲ 62.5%
62.51M▼ 33.1%
36.88M▼ 41.0%
14.13M▼ 61.7%
7.23M▼ 48.8%
338.29M▲ 4577.1%
97.83M▼ 71.1%
21.83M▼ 77.7%
35.48M▲ 0%
Equity Growth %
338.11%62.5%-33.07%-41.01%-61.68%-48.82%4577.09%-71.08%-77.69%-262.42%
Book Value per Share
0.120.150.100.050.020.0132.804.210.050.05
Total Shareholders' Equity
57.48M93.4M62.51M36.88M14.13M7.23M293.47M92.16M21.83M35.48M
Common Stock
3K3K3K4K4K5K8K9K79K13K
Retained Earnings
-54.55M-82.44M-122.06M-166.89M-196.09M-212.15M-479.78M-731.17M-858.25M-879.47M
Treasury Stock
0-230K-1.04M-1.04M-1.04M-1.04M-1.78M-2M-2.14M-2.22M
Accumulated OCI
-1.28M-2.09M17K0008K15K39K25K
Minority Interest
00000044.82M5.67M00

CBUS Cash Flow Statement

Cibus, Inc. (CBUS) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-12.79M-20.25M-31.95M-43.67M-18.81M-19.36M-46.21M-58.04M-50.59M-50.25M
Operating CF Margin %
-2516.73%-8581.36%-437.92%-183.1%-72.39%-12333.76%-2543.2%-1361.87%-1390.24%-
Operating CF Growth %
-38.41%-58.4%-57.77%-36.68%56.93%-2.94%-138.64%-25.61%12.84%40.36%
Net Income
-25.98M-27.9M-39.61M-44.84M-29.2M-16.89M-267.63M-282.71M-127.08M-101.42M
Depreciation & Amortization
551K1.08M1.61M1.87M2.34M1.53M4.69M6.86M5.92M5.46M
Stock-Based Compensation
12.09M4.38M9.18M4.97M2.09M4M010.75M8.19M5.37M
Deferred Taxes
0000000000
Other Non-Cash Items
12.42M11K00-1.53M-5.12M215.76M206.68M60.06M46.54M
Working Capital Changes
552K2.17M-3.12M-5.68M7.49M-2.88M961K383K2.32M-4.35M
Change in Receivables
110K0-1.12M-3.77M4.89M01.7M-512K538K-753K
Change in Inventory
667K0-2.59M1.21M1.38M00000
Change in Payables
665K-193K259K-148K-360K-229K2K-188K720K-1.56M
Cash from Investing
-779K-1.8M-2.97M-13.48M11.2M-1.52M55.06M-808K-578K-359K
Capital Expenditures
-779K-1.85M-2.97M-1.79M-497K-1.52M-4.32M-808K-578K-402K
CapEx % of Revenue
153.35%782.63%40.69%7.49%1.91%968.15%237.81%18.96%15.88%9.38%
Acquisitions
00000059.38M0043K
Investments
----------
Other Investing
050K0-11.7M11.7M00000
Cash from Financing
65.2M60.67M-330K15.41M3.74M9.99M20.32M40.6M46.65M57.34M
Debt Issued (Net)
6.96M1.24M139K1.16M-364K-376K-194K-879K-1.11M-1.22M
Equity Issued (Net)
58.24M57.71M344K15M4.38M11.54M18.76M43.9M47.9M59.55M
Dividends Paid
0000000000
Share Repurchases
0-230K00000000
Other Financing
01.73M-813K-751K-274K-1.17M1.76M-2.42M-142K-991K
Net Change in Cash
51.64M▲ 0%
38.62M▼ 25.2%
-35.18M▼ 191.1%
-41.75M▼ 18.7%
-3.87M▲ 90.7%
-10.89M▼ 181.7%
29.17M▲ 367.8%
-18.27M▼ 162.6%
-4.51M▲ 75.3%
6.74M▲ 0%
Free Cash Flow
-13.56M▲ 0%
-22.1M▼ 62.9%
-34.92M▼ 58.0%
-45.46M▼ 30.2%
-19.31M▲ 57.5%
-20.88M▼ 8.2%
-50.53M▼ 142.0%
-58.85M▼ 16.5%
-51.17M▲ 13.1%
-50.65M▲ 0%
FCF Margin %
-2670.08%-9363.98%-478.62%-190.59%-74.3%-13301.91%-2781.01%-1380.83%-1406.13%-1181.8%
FCF Growth %
31.01%-62.92%-58.02%-30.18%57.53%-8.16%-141.96%-16.47%13.05%11.54%
FCF per Share
-0.03-0.04-0.05-0.07-0.03-0.04-4.90-2.53-0.11-0.08
FCF Conversion (FCF/Net Income)
0.49x0.73x0.81x0.97x0.64x1.15x0.17x0.23x0.40x0.50x
Interest Paid
0001.46M1.43M00000
Taxes Paid
0000000000

CBUS Key Ratios

Cibus, Inc. (CBUS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
-73.6%-36.98%-50.82%-90.23%-114.49%-158.12%-154.91%-115.28%-212.41%-220.7%
Return on Invested Capital (ROIC)
-203.03%-145.18%-146.63%-106.33%-76.49%-93.46%-137.48%-86.15%-25.33%-25.39%
Gross Margin
-8.46%-358.05%-27.19%-47.28%-9.89%-877.07%78.26%100%-62.76%72.07%
Net Margin
-5114.17%-11820.76%-542.93%-187.98%-112.36%-10758.6%-14729.06%-5898.36%-3492.31%-2366.33%
Debt / Equity
0.18x0.20x0.30x0.54x1.26x1.92x0.07x0.37x12.28x7.78x
Interest Coverage
-25719.00x-21.19x-25.59x-30.24x-19.40x-192.46x-16.87x-7.27x-2.73x-3.77x
FCF Conversion
0.49x0.73x0.81x0.97x0.64x1.15x0.17x0.23x0.40x0.50x
Revenue Growth
27.32%-53.54%2991.53%226.91%8.96%-99.4%1057.32%134.56%-14.62%-9.79%
Related:CBUS Dividend History·CBUS Revenue History·CBUS Price History·CBUS P/E History·CBUS Financial Ratios·CBUS Institutional Holders

CBUS SEC Filings & Documents

Cibus, Inc. (CBUS) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 14, 2026·SEC

Material company update

Apr 10, 2026·SEC

Material company update

Mar 27, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 17, 2026·SEC

FY 2025

Mar 20, 2025·SEC

FY 2024

Mar 21, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 14, 2026·SEC

FY 2025

Nov 13, 2025·SEC

FY 2025

Aug 14, 2025·SEC

CBUS Frequently Asked Questions

Cibus, Inc. (CBUS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Cibus, Inc. (CBUS) reported $4.3M in revenue for fiscal year 2025. This represents a 237% increase from $1.3M in 2015.

Cibus, Inc. (CBUS) saw revenue decline by 14.6% over the past year.

Cibus, Inc. (CBUS) reported a net loss of $101.4M for fiscal year 2025.

Dividend & Returns

Cibus, Inc. (CBUS) has a return on equity (ROE) of -212.4%. Negative ROE indicates the company is unprofitable.

Cibus, Inc. (CBUS) had negative free cash flow of $50.7M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in CBUS back in 2015?

Total return calculator · dividends reinvested · 11+ years of data

See returns →

How much would $100/month in CBUS be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →